Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation

OBJECTIVES: B cell depletion by rituximab (RTX) is an effective treatment for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV). However, peripheral B cell phenotypes and the selection criteria for RTX therapy in AAV remain unclear. METHODS: Phenotypic characterization of c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: Miyazaki, Yusuke, Nakayamada, Shingo, Kubo, Satoshi, Ishikawa, Yuichi, Yoshikawa, Maiko, Sakata, Kei, Iwata, Shigeru, Miyagawa, Ippei, Nakano, Kazuhisa, Tanaka, Yoshiya
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7294638/
https://ncbi.nlm.nih.gov/pubmed/32539843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-02215-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados